Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Because he wants the NIR debt to be retired with as few shares as possible, is my guess. NIR agreed to have more than 1/2 it's debt converted to shares as per the debt restructure PR. This happens if the price is as high as possible upon conversion. They owe more to NIR than to him, so that is more of a priority.
The real fight is to reduce the number of shares outstanding. If the company signals that is coming, look out by November 18th, this could be .005 - .01.
I'm expecting answers to post here any minute.
Bad News / Good News
The bad news:
Via email I have learned The CEO's Video Q&A was delayed because of techinical issues at the studio. He didn't even go to the studio to do it. Apparently they are going to reschedule in a few days, maybe as early as by the end of the week according to their email.
The good news:
I asked company representative if in the interim, CEO would agree to answer a few questions with permission to post for Ihub exclusively. He agreed..
I asked questions about a few major topics we've been discussing lately here about EPGL. Will post as soon as I have them.
you going to buy 10mm?
uh huh. lol
Gotta watch these posts peeps. This guy claims to have been in it since last year. LOL.
CEO says no to dilution:
"Nothing is going to be implemented without the expressed approval of our shareholder group. That being said, it is not our intention to implement a plan that will result in dilution for our shareholders. We are acutely cognizant of the negative vote of our shareholder group when a reverse split was proposed last year. Nothing in any of the press releases issued by our company makes mention of a reverse split or increase in authorized shares."
CEO Q&As from past:
Can one of the moderators please get these back into the combined DD?
Previous CEO Q&A's
Q Congratulations on the new EP Health Sciences Division opening. Is the MPDD device FDA approved and do you consider that an asset in getting it accepted not only domestically, but internationally as well?
A The MPDD is approved by the FDA. What is necessary is to marry this device with the proprietary intervention therapy developed by Dr. Marcus which itself has its genesis in the treatment therapy pioneered by Hans Kraus, MD, the physician who
treated President John Kennedy for his Addisons Disease. Together, this intervention potentially can help millions of people around the world suffering from chronic back and neck pain and avoid unnecessary surgeries that are often unsuccessful in eliminating pain. I am one of those who had been diagnosed with compressed/bulging discs in C-2-C-7 and have tried many types of therapies including acupuncture, nerve blocks, facet injections and, recently was a candidate for a spinal fusion. Dr. Marcus’ MPDD and therapy changed all of that and I have been pain free for months. I also know that Dr. Marcus has had great results working with veterans of Iraq and Afghanistan who sustained significant painful back and neck injuries as a result of combat operations in those theaters of operation so the potential for benefit is clearly there. But as we all know, medicine in this country requires new innovative therapies pass muster with some of the most rigorous clinical trials in the world, so these things often take time. If shareholders are really interested in learning more about the MPDD and accompanying therapy, they should come to Dallas November 18-19 to the World Congress on Disabilities (www.thewcd.org) and attend the lecture given by Dr. Marcus on this subject. Indeed, attending the WCD will give you and any other shareholder who attends a first class perspective on the scope of what we do both in the civilian and military sectors. And yes, having FDA approval is generally regarded as a very important step in the process of gaining acceptance in the international and domestic medical community. But here again it is not so much the device itself as its application with the intervention therapy pioneered by Dr. Marcus that is important too.
Q You recently announced you have reached a restructure agreement with the major debt holders. With this restructure in place, can all your goals be accomplished without raising authorized share amounts or reverse split?
A We have reached an agreement in principle with our major debt holder, NIR and the details of that agreement need to be solidified and then voted on by shareholders. Nothing is going to be implemented without the expressed approval of our shareholder group. That being said, it is not our intention to implement a plan that will result in dilution for our shareholders. We are acutely cognizant of the negative vote of our shareholder group when a reverse split was proposed last year. Nothing in any of the press releases issued by our company makes mention of a reverse split or increase in authorized shares.
Q As we understand it, you are a major debt holder. Have you agreed to have more than 1/2 of your debt converted to shares too? Would this not mean you have more incentive than ever to raise shareholder equity?
A Yes, it is my intention to convert 50% of the amounts due and owing to me into equity as a condition of the restructuring agreement. Inasmuch as I am the second largest creditor next to NIR, I should think this would be viewed as a fairly important step and a reaffirmation of my commitment to this company and its mission. It also reinforces in me and I hope others in management additional incentive to try to increase shareholder value. Thus our value is aligned with those of our shareholders, a fact that tends to escape some people at times.
Q. With the new Health Sciences Division, do you anticipate EPGL will own and market biotech devices and other products?
A. One only has to read the PR headline about our new EP Health Sciences Division for the answer to that question. Nobody should be confused about that. EPGL is moving into significant new areas with the health sciences division. Our mission at EP has always been to help those impacted with disability and pain in all the ways we possibly can. There are many new things in development and announcements will come when it is appropriate to make such things public. Please continue to monitor the news about EPGL in the coming weeks and months ahead. We encourage all shareholders to attend the WCD in person or via the live webcast. You will learn a lot about EP and what it is all about.
-Joe Valenzano, CEO EP Global Communications, EP Health Sciences 9-26-2010
It's in the Q&As. With the restructure there is no dilution as stated by the company. In fact CEO is converting his own debt from co. to shares. This is rather telling of his belief the stock is undervalued. NIR is the other main debt holder who cannot dilute anymore because they have agreed to participate in the restructure and reduce half their debt to shares also. This is HUGE. The due dilligence is right there to be read above.
This is a pull-back buying opportunity. Because the float is high, the churning takes longer and it presents opportunities to buy low sell high. But the trend will continue up to November, imo. If they reduce float in anyway with this restructure, look out it will move up quickly on that news.
We still have volume, we still have news. This is a dip to buy into for sure, imo. Wish I could buy more here but I'm tapped. Last time I said this, the stock tripled from there, just to make it that much more painful for me.
There's no doubt a reduction in float would be huge. But it's not dilution. NIR is out of shares and nobody in their right mind would be selling with all the news that is coming. Bashers want shares too, they just want them cheaper so they can flip. It's working right now.
We have contract with Marines and Army (coming) worth over $1.1M cash. $2M earlier in the year with Exceptional Family Training contract and Senate Defense Appropriations grant. Web Md contract, International content licensing agreement on the way. Restructure with debt on the way, equal to $5M at least being put back onto the books.
Agreed. There have been a few people here who have caused a lot of newbies to get scared out of their shares. They know exactly what they are doing and it has worked. Pose as shareholders who are "concerned" and "worried". Old school technique, but it works. All you need to know is right above in the DD. Nothing has changed and we have even more news coming.
all they would say is it is for investors and will address recent positive developments.
I like how you're trying to cause doubt and set expectations high. Nice technique in trying to get more at a lower price. But, I have to admit you are succeeding for now.
News hasn't changed though, it's all good. Weak hands give others buying opportunities. This is one.
CEO's Q&A Video Update
Via email "Interview is happening today. Video out later tonight or tomorrow." Fyi.
oh, ok. lol
Weak hands get suckered out of their shares by people like you. Trying to get back in eh?
Nice move. Wish I could have done that too.
No it will not incrrease common.Simply readthe DD and the CEO Q&A which I reposted earlier today. CEO has stated there will be no dillition.
Why thanks Suetta, but Ill take care of myself. Have a great weekend!
I'm referring to the announced restructuring agreement which would see more than 1/2 the debt converted to shares.
Earlier in the year they got $2M from the 2010 military appropriations bill. Now they have the US Marines contract,Army on the way, WebMD contract. FDA approved devices. Restructuring which will effectively add back more than $6M. I think EP may be a bit undervalued here.
Previous CEO Q&A's
Q Congratulations on the new EP Health Sciences Division opening. Is the MPDD device FDA approved and do you consider that an asset in getting it accepted not only domestically, but internationally as well?
A The MPDD is approved by the FDA. What is necessary is to marry this device with the proprietary intervention therapy developed by Dr. Marcus which itself has its genesis in the treatment therapy pioneered by Hans Kraus, MD, the physician who
treated President John Kennedy for his Addisons Disease. Together, this intervention potentially can help millions of people around the world suffering from chronic back and neck pain and avoid unnecessary surgeries that are often unsuccessful in eliminating pain. I am one of those who had been diagnosed with compressed/bulging discs in C-2-C-7 and have tried many types of therapies including acupuncture, nerve blocks, facet injections and, recently was a candidate for a spinal fusion. Dr. Marcus’ MPDD and therapy changed all of that and I have been pain free for months. I also know that Dr. Marcus has had great results working with veterans of Iraq and Afghanistan who sustained significant painful back and neck injuries as a result of combat operations in those theaters of operation so the potential for benefit is clearly there. But as we all know, medicine in this country requires new innovative therapies pass muster with some of the most rigorous clinical trials in the world, so these things often take time. If shareholders are really interested in learning more about the MPDD and accompanying therapy, they should come to Dallas November 18-19 to the World Congress on Disabilities (www.thewcd.org) and attend the lecture given by Dr. Marcus on this subject. Indeed, attending the WCD will give you and any other shareholder who attends a first class perspective on the scope of what we do both in the civilian and military sectors. And yes, having FDA approval is generally regarded as a very important step in the process of gaining acceptance in the international and domestic medical community. But here again it is not so much the device itself as its application with the intervention therapy pioneered by Dr. Marcus that is important too.
Q You recently announced you have reached a restructure agreement with the major debt holders. With this restructure in place, can all your goals be accomplished without raising authorized share amounts or reverse split?
A We have reached an agreement in principle with our major debt holder, NIR and the details of that agreement need to be solidified and then voted on by shareholders. Nothing is going to be implemented without the expressed approval of our shareholder group. That being said, it is not our intention to implement a plan that will result in dilution for our shareholders. We are acutely cognizant of the negative vote of our shareholder group when a reverse split was proposed last year. Nothing in any of the press releases issued by our company makes mention of a reverse split or increase in authorized shares.
Q As we understand it, you are a major debt holder. Have you agreed to have more than 1/2 of your debt converted to shares too? Would this not mean you have more incentive than ever to raise shareholder equity?
A Yes, it is my intention to convert 50% of the amounts due and owing to me into equity as a condition of the restructuring agreement. Inasmuch as I am the second largest creditor next to NIR, I should think this would be viewed as a fairly important step and a reaffirmation of my commitment to this company and its mission. It also reinforces in me and I hope others in management additional incentive to try to increase shareholder value. Thus our value is aligned with those of our shareholders, a fact that tends to escape some people at times.
Q. With the new Health Sciences Division, do you anticipate EPGL will own and market biotech devices and other products?
A. One only has to read the PR headline about our new EP Health Sciences Division for the answer to that question. Nobody should be confused about that. EPGL is moving into significant new areas with the health sciences division. Our mission at EP has always been to help those impacted with disability and pain in all the ways we possibly can. There are many new things in development and announcements will come when it is appropriate to make such things public. Please continue to monitor the news about EPGL in the coming weeks and months ahead. We encourage all shareholders to attend the WCD in person or via the live webcast. You will learn a lot about EP and what it is all about.
-Joe Valenzano, CEO EP Global Communications, EP Health Sciences 9-26-2010
I think we finally pass 6 this week. That's my gut feeling. CEO Video interview coming Monday-Tuesday. Should be very insightful.
Have a great weekend, ALL.
Friday's close...
was a $30 paint job in case you missed it. Stock had strong buying into close at the ask of 0004 and should be showing 0004. Someone painted a sell at bid of .0003 for $30 in proceeds during last seconds of trade. LOL.
There should be a minimum trade rule in last 15 minutes of trading session. imo
I think we will see one Monday.
There's definitely news being made Monday night. CEO Video Q&A will be out.
Read the DD please. Read what the CEO himself says. Stick to facts from the company. Also, the CEO is converting 1/2 his debt into company shares in the restructure. Do you think he wants dillution?
PR UPDATE: VIDEO PR MONDAY NIGHT
Confirmation from company via email, the CEO, Joe M. Valenzano Jr. will be interviewed live Monday afternoon. The video will be posted on YouTube immediately thereafter Monday night and will also be available for viewing on www.eparent.com and other sites.
From email:
"This will be an important investor oriented video interview with significant information directly from the CEO himself on our recent activities. We encourage all investors to be watching as it will be very valuable and informative as we move closer to November's WCD conference in Dallas Texas, November 18-19, 2010."
Company said they will publicize a link as soon as it is up Monday night.
We will see 30% green now monday and hopefully 60% later in the day as people anticipate the CEO's VIDEO PR Monday night.
strong buying into close all to be brought down by a $30 trade. This system is ridiculous.
sooner this company can get institutional investors on board the better. these a#*hole mm's allowing that are scum.
painted 3 short a-hole!
Nice Flopps!
WOW! Great find. He is a very good and moving speaker. Look forward to Monday night's new video for investors! Yeeeeeow!
EOD exodus of shorts?
Lowman, dude you are cool. You've made your point. I'm trying to get you guys to move on here. Shake hands and move on. I said same thing to him. Truthfully, it becomes not about EPGL but about you guys and that's not what we should be doing.
RE, I think lowman is referring to the sarcasm you are using. Maybe some people might really take you serious on some of those posts, ie., "Why aren't people dumping this?" I saw earlier. Some people less familiar may come in and get confused.
But I agree, you have had some good solid posts. Both you and Lowman, so come on and shake hands. Let's move on.
Yeah, spread the word on that folks. That could be more informative than anything so far.
Agreed 100%.